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Abstract
Background: Vanadium pentoxide (V2O5) exposure is a cause of occupational bronchitis and airway fibrosis.
Respiratory syncytial virus (RSV) is a ubiquitous pathogen that causes airway inflammation. It is unknown whether
individuals with pre-existing respiratory viral infection are susceptible to V2O5-induced bronchitis. We hypothesized
that respiratory viral infection will exacerbate vanadium-induced lung fibrosis.
Methods: In this study we investigated the effect of RSV pre- or post-exposure to V2O5 in male AKR mice. Mice
were pre-exposed by intranasal aspiration to RSV or media vehicle prior to intranasal aspiration of V2O5 or saline
vehicle at day 1 or day 7. A parallel group of mice were treated first with V2O5 or saline vehicle at day 1 and day 7
then post-exposed to RSV or media vehicle at day 8.
Results: V2O5-induced airway inflammation and fibrosis were decreased by RSV pre- or post-exposure. Real time
quantitative RT-PCR showed that V2O5 significantly increased lung mRNAs encoding pro-fibrogenic growth factors
(TGF-b1, CTGF, PDGF-C) and collagen (Col1A2), but also increased mRNAs encoding anti-fibrogenic type I
interferons (IFN-a,- b) and IFN-inducible chemokines (CXCL9 and CXCL10). RSV pre- or post-exposure caused a
significantly reduced mRNAs of pro-fibrogenic growth factors and collagen, yet reduced RNA levels of anti-
fibrogenic interferons and CXC chemokines.
Conclusions: Collectively these data suggest that RSV infection reduces the severity of V2O5-induced fibrosis by
suppressing growth factors and collagen genes. However, RSV suppression of V2O5-induced IFNs and IFN-inducible
chemokines suggests that viral infection also suppresses the innate immune response that normally serves to
resolve V2O5-induced fibrosis.
Introduction
A variety of metal oxides cause occupational lung dis-
eases referred to as pneumoconioses. Vanadium is a
transition metal commonly found in various types of
ores, coals, and oil [1]. Vanadium pentoxide (V2O5), the
most common form of vanadium, is the primary form
found in industrial exposure situations [2]. In addition,
atmospheric emissions released from power plants that
burn coal and oil contribute ~64,000 metric tons of
vanadium into the atmosphere each year [2]. Occupa-
tional exposure to V2O5 d u s ti sc o m m o ni nc o a l -
burning power plants and individuals exposed to inhaled
V2O5-containing fly ash suffer from chronic bronchitis
and reduced lung function [3,4]. The consequences of
environmental exposure to lower levels of V2O5 on
human health remain unclear, in part because air pollu-
tion particulates are a complex mixture of many organic
and inorganic components, including a variety of metals
[5]. However, epidemiologic evidence indicates that indi-
viduals at greatest risk for exposure to particulate air
pollution are those with pre-existing respiratory diseases
such as asthma and viral bronchitis [6,7].
Respiratory syncytial virus (RSV) is a ubiquitous virus
that causes airway inflammation and bronchitis [8,9]. The
virus is an enveloped negative-sense single-stranded RNA
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its isolation, RSV has been identified as a leading cause of
epidemic respiratory tract illness in children in the United
States and worldwide [11]. Although RSV exposure in the
human population occurs at a very early age, immunity is
incomplete after RSV infection and secondary infections
can occur throughout life. Airway epithelial cells are the
primary target of RSV infection, and they respond to the
infection by producing a variety of mediators involved in
lung immune/inflammatory responses, such as cytokines,
chemokines, and interferons [12].
Occupational bronchitis and airway fibrosis caused by
V2O5 is recapitulated in rats or mice exposed by intra-
tracheal instillation or pharyngeal aspiration [13,14]. In
these studies, V2O5 causes airway and interstitial fibrosis
that partially resolves within several weeks after expo-
sure. Profibrogenic growth factors, including platelet-
derived growth factor (PDGF) and its receptor, are
elevated in rats exposed to V2O5 [15]. The PDGF system
plays a pivotal role in orchestrating myofibroblast migra-
tion and proliferation at sites of forming fibrotic lesions
[16]. Moreover, tyrosine kinase inhibitors selective for
PDGF or EGF receptors reduce V2O5-induced fibrosis
in rats [17]. The partial resolution of V2O5-induced
fibrotic lung lesions in rodents is due at least in part to
the potent action of V2O5 as an activator of STAT-1, a
transcription factor that mediates fibroblast growth
arrest and apoptosis [18]. Moreover, STAT-1-deficient
mice are more susceptible to pulmonary fibrosis follow-
ing lung injury [19].
Studies with human cells also indicate that V2O5 induces
both pro-fibrogenic and anti-fibrogenic factors. For exam-
ple, gene expression profiling of normal human lung fibro-
blasts exposed to V2O5 in culture show increased levels of
pro-fibrotic and angiogenic growth factors (PDGF,
CTGF, HB-EGF, VEGF) as well as protective IFNs [20].
The production of pro-fibrogenic growth factors and anti-
fibrogenic IFNs and chemokines is dependent on the gen-
eration of reactive oxygen species [21,22]. In general, the
production of both pro-fibrogenic and anti-fibrogenic
mediators by human lung cells in response to V2O5 is con-
sistent with a partially resolving lung fibroproliferative
response in mice or rats exposed to V2O5 by a single intra-
tracheal or pharyngeal aspiration.
The hypothesis of this research is that respiratory viral
infection will exacerbate vanadium-induced lung fibrosis.
I nc o n t r a s t ,w er e p o r tt h a tR S Vp r e -o rp o s t - e x p o s u r e
reduces V2O5-inflammation, cell proliferation, and fibrosis
in male AKR mice. Moreover, RSV pre- or post-exposure
significantly reduced mRNA levels of pro-fibrogenic
growth factors and collagen, and yet also reduced RNA
levels of anti-fibrogenic interferons and CXC chemokines.
Collectively these data suggest that RSV infection reduces
the severity of V2O5-induced fibrosis by suppressing
pro-fibrogenic growth factors and collagen genes.
However, RSV suppression of V2O5-induced IFNs and
IFN-inducible chemokines also suggests that viral infec-
tion has a negative effect on the immune response trig-
gered by V2O5 exposure. These results have potentially
important ramifications, since a wide variety of metal
oxides cause occupational lung diseases and RSV infection
is commonplace.
Materials and methods
Animals
Six-week old male pathogen-free CDF AKR mice were
purchased from The Jackson Laboratory (Bar Harbor, ME)
and housed in an Association for Assessment and Accred-
itation of Laboratory Animal Care (AAALAC)-accredited
facility that was humidity and temperature controlled.
AKR mice were tested as they are susceptible to both RSV
and metal induced bronchitis [23]. Mice were housed in
microisolator cages on Alpha-dri cellulose bedding and
supplied water and cereal-based diet NIH07 (Zeiger Broth-
ers., Gardners, PA) ad libitum. The animal studies were
approved by The Hamner Institutes for Health Sciences
Institutional Animal Care and Use Committee.
Experimental design
Animals were randomly assigned to treatment groups
(seven mice per group) and acclimated for two weeks.
Treatment groups included a media control (media
collected from non-inoculated Vero cells), V2O5,
RSV pretreatment, RSV post-treatment, RSV pretreat-
ment+V2O5, or RSV post-treatment+V2O5 (Fig. 1). RSV
strain A2 (a kind gift from Dr. Ralph Tripp, University
of Georgia, Athens) was propagated in Vero cells and
concentrated using Amicon Ultra filters (Millipore Cor-
p o r a t i o n ,B e d f o r d ,M A ) .R S Vw a sd i l u t e dt o6×1 0
5
PFU in a 100 μl dose and inoculated intranasally into
both nares on days -1 and 8 under light isoflurane
anesthesia. A pilot group of mice were exposed to RSV
and lung harvested at day 4 to determine the presence
of RSV in whole lung tissue by ELISA as described
below. V2O5 (Sigma-Aldrich Chemical, St. Louis, MO)
was suspended in PBS and sonicated for 30 minutes.
Mice were given intranasal inoculation of 50 μlo fV 2O5
(4 mg/kg) or PBS into both nares on days 0 and 7
under light isoflurane anesthesia. Preliminary studies
demonstrated that intranasal administration of either
RSV or V205 resulted in even distribution in all lung
lobes (data not shown). Negative control animals were
treated with PBS. Animals were euthanized at 21 days
following initial particle exposure.
Necropsy and preparation of lung tissues
One hour prior to euthanasia, mice received a single
intraperitoneal injection of 50 mg/kg body weight of
Turpin et al. Respiratory Research 2010, 11:20
http://respiratory-research.com/content/11/1/20
Page 2 of 11bromodeoxyuridine (BrdU; Sigma-Aldrich). The lungs
were lavaged with PBS as described below, the right
lung lobes were snap-frozen in liquid nitrogen and
stored at -80°C and used for RNA isolation and collagen
assay as described below. The left lungs were pressure-
infused intratracheally at 20 cm H20w i t h1 0 %n e u t r a l -
buffered formalin. The same lungs were lavaged and
sampled for histopathology, collagen, quantitative PCR,
and ELISA assays to allow for direct comparison of
assay results. Lungs were fixed for approximately
48 hours and then changed into 70% ethanol. Three
cross-sectional portions of the left lung were embedded
in paraffin, sectioned at 5 μm, and stained with Mas-
son’s trichrome, hematoxylin and eosin, or immunos-
tained for BrdU as described below.
Bronchoalveolar lavage
Mice were euthanized by pentobartital overdose and
lungs were lavaged five times with 1-ml volumes of PBS.
Bronchoalveolar lavage fluid (BALF) collected from the
first two recovered lavages were pooled and placed on
ice. The subsequent three lavages were pooled and placed
on ice. BAL cells collected by centrifugation were resus-
pended in culture medium and enumerated using an
automated cell counter (Model ZM, Coulter, Marietta,
GA). Cytospins were prepared with 10
5 cells per slide.
Cell differential counts, performed on HEMA-3 (Fisher
Scientific, Pittsburgh, PA) stained cytocentrifuge slide
preparations, were based on a total number of 350 cells.
Total protein and lactate dehydrogenase (LDH) in cell-
free BALF from the first two pooled lavages were ana-
lyzed spectrophotometrically using a COBAS FARA II
(Roche Diagnostic Systems Inc., Montclair, NJ).
Lung histopathology and pathology scoring
The lungs from the 21 day time point were scored for
fibrosis according to our previously reported method
[24]. The left lung lobe was formalin-fixed, embedded in
paraffin and cut in 5-μm sections. The lungs were
scored for the amount of collagen present (based on
Masson’s trichrome-stained sections), the thickness of
the alveolar walls, and the number of fibroblast-like cells
associated with the lesions. Sections were scored blindly
on a relative scale where zero represented the levels of
these parameters in the PBS control group, 1 represent-
ing minimal fibrosis, 2 representing mild fibrosis, 3
representing moderate fibrosis, 4 representing marked
fibrosis, and 5 representing severe fibrosis.
Bromodeoxyuridine (BrdU) immunohistochemistry and
Cell Proliferation
Cell labeling indices were determined in the bronchiolar/
alveolar region and in the bronchus-associated lymphoid
tissue for each animal, and the mean labeling index was
calculated for each group of eight animals. The BALT
w a se x a m i n e da si ti sb e l i e v e dt of a c i l i t a t ep r i m a r y
immune response to respiratory infection and would
serve as a marker for inflammation in the lung [25].
RSV ELISA
Lung samples from mice were analyzed on an antigen
capture ELISA modified from previously described pro-
tocols [26,27]. A goat anti-RSV polycolonal antibody
(0601, ViroStat, Portland, ME) was diluted 1:500 in
Tris-buffered saline (TBS), 100 μl added per well and
incubated overnight at 4°C. Plates were washed with
TBS+ 0.05% Tween 20 (TBST) and blocked with 200 μl
of TBST with 1% BSA for 1 h at room temperature.
Plates were washed three times to remove blocking buf-
fer. Lung homogenates were prepared by homogenizing
the right accessory lung lobe in 500 ml of PBS for 5 s
with a tissue homogenizer. Lung homogenates were
diluted 1:5 and 100 μl added per well in duplicate and
incubated overnight at 4°C. After washing, 100 μlo fa
Figure 1 Experimental Design for exposing adult male AKR mice to RSV and V2O5. A pilot group of mice received an intranasal exposure
to RSV or media vehicle alone to test for infection in the lungs at day 4. All other histopathology and gene expression endpoints listed were
assessed at 21 days following intranasal exposure to RSV (6 × 10
5 PFU) and/or V2O5 (4 mg/kg) as described in Methods.
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ViroStat) diluted 1:500 in TBST with 1% BSA was
added and incubated for 1 hr at room temperature.
Plates were then washed three times and 100 μlo f
ExtrAvidin-peroxidase (E2886, Sigma-Aldrich) diluted
1:1000 in TBST with 1% BSA. Plates were washed three
times and detected with 3,3’,5,5’-Tetramethylbenzidine
(TMB, T5524, Sigma-Aldrich). After 30 min incubation,
the reaction was stopped with 0.5 N H2SO4.T h ev a l u e s
are expressed as the OD observed at 450 nm.
Collagen Assay
The right cranial lobe of each mouse lung was sus-
pended in PBS at 50-100 mg tissue per ml and homoge-
nized for 10 s with a Tissuemiser homogenizer (Fisher
Scientific). Cellular debris was pelleted by centrifugation
and the supernatant analyzed for total protein with the
BCA Assay Kit (Pierce/ThermoFisher Scientific, Rock-
ford, IL) according to the manufacturer’s instructions.
The Sircol™ Soluble Collagen Assay kit (Biocolor Ltd.,
Northern Ireland) was used to extract collagen from
duplicate samples by using 100 μl of supernatant mixed
with acetic acid and 500 μl of Sircol Dye Reagent
according to the manufacturer’s instructions. Similarly
prepared collagen standards (10-50 μg) were run in par-
allel. Collagen was pelleted by centrifugation; pellets
were washed twice with denatured alcohol and dried
prior to suspension in Alkali reagent. Absorbance at 540
nm was read on a Multiskan EX microplate spectro-
photometer (ThermoFisher Scientific) microplate reader
with Ascent software. Data were expressed as μgo f
soluble collagen per mg of total protein.
Taqman quantitative RT-PCR
Total RNA from the right anterior lung was isolated
using TRIZOL reagent (Invitrogen, Carlsbad, CA), fol-
lowed by RNA cleanup performed using RNeasy Midi
spin columns (Qiagen, Valencia, CA). One microgram of
total RNA was reverse transcribed at 48°C for 30 minutes
using Moloney murine leukemia virus reverse transcrip-
tase (Eurogentec, San Diego, CA) in 1× RT buffer, 5 mM
MgCl2, 500 μM of each dNTP, 2.5 μM of random nona-
mers, and 0.4 U/μL RNase inhibitor in a volume of 100
μl. Twenty nanograms of the RT product was amplified
using Taqman Gene Expression Assays specific for plate-
let-derived growth factor receptor alpha (PDGFRa),
PDGF-A, PDGF-C, transforming growth factor beta-1
(TGF-b1), connective tissue growth factor (CTGF), type I
procollagen (COL1A2), vascular endothelial growth fac-
tor (VEGF) and 18S on the Applied Biosystems 7900
Prism® Sequence Detection System (Applied Biosytems,
Foster City, CA). The PCR conditions and data analysis
were performed according to the manufacturer’s protocol
described in User bulletin no.2, Applied Biosystems
Prism 7700 Sequence Detection System. Gene expression
was measured by the quantitation of cDNA converted
from mRNA corresponding to the target genes relative to
the vehicle-treated control groups and normalized to
eukaryotic 18S reference endogenous control. Relative
quantitation values (2
-ΔΔCT) were expressed as fold-
change over controls.
Data and statistical analysis
All graphs were constructed and statistical analysis per-
formed using GraphPad Prism® software v. 5.00 (Graph-
Pad Software, Inc., San Diego, CA). A one-way ANOVA
with a post-hoc Tukey test was used to identify signifi-
cant differences among treatment groups.
Results
We first sought to determine whether RSV would infect
the lungs of AKR mice after a single intranasal inocula-
tion in the absence of any V2O5 exposure. Using an RSV-
specific ELISA, we found that the intranasal delivery of
RSV caused infection in the lungs of mice after 4 days
(Fig. 2). An optical density (O.D.) value of 0.2 represented
no virus. RSV infection was accompanied by a transient
inflammatory response in the airways of AKR mice
observed at 4 days (data not shown). Collectively these
data show that the intranasal inoculation of RSV resulted
in viable, replicating RSV within the lungs of AKR mice.
Lung samples were also analyzed at day 21 in all mice
and no RSV was detected (data not shown) as would be
expected. In addition, the effect of V2O5 on RSV replica-
tion was evaluated in vitro using cultured human lung
epithelial H292 cells. In these in vitro experiments, V2O5
Figure 2 Detection of RSV in the lungs of male AKR mice 4
days after a single intranasal aspiration of virus-containing
media or media vehicle alone. The presence of RSV in the lungs
was measured by ELISA as described in Methods. Data were
analyzed by Student’s t-test. ***P < 0.001 compared to Media.
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post treatment (data not shown).
Airway fibrosis, increased airway wall thickness due to
increased collagen and/or fibroblasts around the airways,
as well as interstitial fibrotic lesions within the lung par-
enchyma, increased septal thickening due to collagen
and/or fibroblasts in the alveolar region, was signifi-
cantly increased by 21 days following a single intranasal
exposure to V2O5 (Fig. 3A). The airway fibrotic response
to V2O5 exposure in AKR mice was qualitatively less
severe in mice that received either pre- or post-RSV
exposure, whereas RSV exposure alone did not appear
different from media control exposed control lung tissue
at 21 days (Fig. 3A). In a blinded pathology evaluation
of the lung sections, the V2O5-induced inflammation
score was significantly reduced by RSV post-exposure,
whereas RSV pre-exposure had no effect on the V2O5-
induced inflammation score (Fig. 3B). The lungs of the
V2O5 treated mice had increased inflammation com-
posed of increased total numbers of cells as well as
increased numbers of neutrophils and lymphocytes. In
addition, V2O5 significantly increased total lung collagen
levels as measured by Sircol assay, but not when mice
were pre- or post-exposed to RSV (Fig. 3C). V2O5 treat-
ment increased the total BAL numbers when give alone
or with RSV post-exposure, while RSV pre-exposure
and RSV pre-exposure+V2O5 levels were similar to con-
trols (Fig 4). V2O5 increased the numbers of neutrophils
and lymphocytes in BAL fluid at 21 days post-exposure
mirroring what was observed inl e s i o ns c o r i n go fl u n g s
(Fig. 4). RSV exposure alone also increased the numbers
of BAL neutrophils and lymphocytes. However, RSV
Figure 3 Lung histopathology at 21 days in male AKR mice treated with RSV and/or V2O5.( A) Representative airway pathology in mice
exposed to V2O5 with or without RSV pre- or post-exposure. Lung sections were stained with Masson’s trichrome to show collagen (blue
staining). (B) Inflammation scores were determined in a blinded manner as described in Methods. Data were analyzed by One-way ANOVA
followed by Tukey’s test. **P < 0.01 or ***P < 0.001 compared to V2O5.( C) Lung collagen was measured by Sircol™ assay as described in
Methods. Data were analyzed by One-way ANOVA followed by Tukey’s test. **P < 0.01 compared to Control.
Turpin et al. Respiratory Research 2010, 11:20
http://respiratory-research.com/content/11/1/20
Page 5 of 11pre- or post-exposure reduced the V2O5-induced
increase in these inflammatory cells by ~50% (Fig. 4).
Cell proliferation, as assessed by BrdU-positive nuclei,
was significantly increased around airways and in the
lung parenchyma of mice 21 days after V2O5 exposure
(Fig. 5). BrdU-positive epithelial and sub-epithelial
mesenchymal cells were observed in the airways and
lung parenchyma of mice exposed to RSV and/or V2O5
(data not shown). BrdU labeling was > 1% in the lungs
of control animals. RSV exposure alone also caused an
increase in cell proliferation, although the number of
BrdU-positive cells were one-third to half of that
observed for V2O5 alone. RSV pre- or post-exposure did
not significantly change the cell proliferation index in
either airways or lung parenchyma (Fig. 5).
We next sought to determine the effect of RSV on the
mRNA levels of growth factors and collagen induced by
V2O5. The mRNAs encoding several pro-fibrogenic
growth factors (TGF-b1, CTGF, and PDGF-C) were sig-
nificantly increased by V2O5 exposure in whole lung
tissue at 21 days post-exposure (Fig. 6). RSV exposure
alone did not significantly increase the mRNA levels of
any of these three growth factors nor was the collagen
(Col1A2) mRNA level increased by RSV alone. However,
RSV pre- or post-exposure completely inhibited V2O5-
induced growth factor and collagen mRNA levels at 21
days (Fig. 6).
Since IFNs and IFN-inducible CXC chemokines have
been suggested to play a role in the resolution of V2O5-
induced fibrogenesis, we also assessed the effect of RSV
on mRNA levels encoding type I IFNs (IFN-a and IFN-b)
and downstream chemokines CXCL9 (Mig) and CXCL10
(IP10). The mRNAs encoding (IFN-a,I F N - b,C X C L 9 ,
and CXCL10 were significantly increased by V2O5 expo-
s u r ei nw h o l el u n gt i s s u ea t2 1d a y sp o s t - e x p o s u r e
(Fig. 7). RSV exposure alone marginally increased
mRNA levels of IFN-a and IFN-b, but did not increase
CXCL9 or CXCL10 mRNAs at 21 days. RSV pre- or
post-exposure completely blocked V2O5-induced mRNA
levels of IFN-a, IFN-b, CXCL9, and CXCL10 (Fig. 7).
Figure 4 Cell differential counts in bronchoavleolar lavage (BAL) fluid at 21 days after exposure to V2O5 in the absence or presence of
RSV pre- or post-exposure showing total numbers of BAL cells recovered by lavage (A) the relative percentages of (B) macrophages,
(C) neutrophils, and (D) lymphocytes. Data were analyzed by One-way ANOVA followed by Tukey’s multiple comparison test. *P < 0.05,
**P < 0.01, or ***P < 0.001 compared to Control.
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RSV is known to exacerbate airway diseases such as cys-
tic fibrosis and asthma [28-30]. Moreover, the toxicity of
air pollutant particles is generally thought to be
increased by viral infections, and conversely, some air
pollutant particles increase viral infections [31,32].
Nevertheless, the effect of respiratory viral infection on
the pathogenesis of occupational lung diseases caused
by the inhalation of metals has not been previously
investigated to our knowledge. We hypothesized that
RSV infection would increase airway fibrosis and remo-
deling caused by V2O5, a transition metal that causes
occupational bronchitis in individuals working in coal
and oil-burning power plants. Surprisingly, we found
that RSV infection before V2O5 exposure reduced the
lung inflammation score, whereas RSV infection after
V2O5 significantly reduced lung inflammation as com-
pared to metal exposure alone. RSV pre- or post-expo-
sure significantly reduced V2O5-induced increases in
neutrophil and lymphocyte infiltration into the lung.
Furthermore, V2O5 exposure alone significantly
increased lung collagen, whereas we observed no signifi-
cant increase in lung collagen in mice that received RSV
before or after V2O5.
The reduction in V2O5-induced fibrosis by RSV infec-
tion was accompanied by a marked reduction in
mRNAs encoding pro-fibrogenic growth factors and col-
lagen. Exposure to V2O5 in the absence of RSV
increased TGF-b1 and collagen mRNA levels several-
f o l da f t e r2 1d a y so fe x p o s u r e .T G F - b1 has long been
regarded as the most potent stimulator of collagen
synthesis during lung fibrosis [33]. RSV exposure alone
caused no induction of TGF-b1o rc o l l a g e nm R N A sa t
21 days and completely suppressed V2O5 induction of
TGF-b1 and collagen mRNAs. CTGF and PDGF-C,
which also mediate collagen deposition and/or fibroblast
survival [16,34], were induced by V2O5 several-fold and
induction was blocked by RSV at 21 days. Therefore,
the overall pattern of RSV effect on V2O5-stimulated
responses was to block pro-fibrogenic signaling. A lim-
itation of our analysis was that we assayed mRNA levels
at 21 days post-V2O5 exposure. It is possible that RSV
caused changes in mRNA levels encoding these pro-
fibrogenic mediators at earlier time points and returned
to baseline levels of expression by 21 days.
The effect of RSV pre-exposure or post-exposure was
previously studied in combination with carbon black
(CB) ultrafine particles using BALB/C mice [26,35]. In
experiments where mice were first exposed to CB and
then RSV, viral titers in RSV + CB mice were lower than
RSV alone on days 2-4 of infection, and yet by day 7 of
expsoure neutrophil numbers, proinflammatory cytokine
mRNA expression, and protein levels of TNF-alpha and
the Th2 cytokine interleukin( I L ) - 1 3w e r ei n c r e a s e di n
the lungs of RSV + CB mice, indicating an exacerbation
of infection [26]. These data indicated that pre-exposure
to ultrafine particles induces an allergic (Th2) immune
response rather than an IFN-g-mediated (Th1) response
production necessary for microbial defense. In a second
study by the same investigators, mice were intratracheally
instilled with CB particles after 3 days of RSV infection
[35]. Neutrophil and lymphocyte numbers were higher
on days 4 and 14 of infection in CB-exposed, RSV-
infected mice. CB exposure also enhanced RSV-induced
airway hyperresponsiveness to methacholine, bronchoal-
veolar lavage (BAL) total protein, and virus-associated
chemokines monocyte chemoattractant protein (MCP-1),
macrophage inflammatory protein (MIP-1 alpha), and
Figure 5 Cell proliferation in the lungs of male AKR mice at 21 days after exposure to V2O5 in the absence or presence of RSV pre- or
post-exposure. Bromodeoxyuridine (BrdU)-positive cells were quantified in (A) lung parenchyma and (B) airways as described in Methods. Data
were analyzed by One-way ANOVA followed by Tukey’s multiple comparison test. *P < 0.05 compared to Control.
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secreted (RANTES). These data demonstrated a synergis-
tic effect of ultrafine CB particles on RSV infection, and
suggest a potential mechanism for increased respiratory
infections in human populations after PM exposure. In
contrast to the studies by Lambert and coworkers
described above, our data show that either pre- or post-
exposure to RSV reduced V2O5-induced lymphocyte and
neutrophil influx into the lung, decreased pro-fibrogenic
growth factor and collagen mRNAs, and reduced inflam-
mation and fibrosis.
As mentioned above, the toxic effects of air pollution
particles is generally thought to be increased by viral
infections [31]. For example, diesel exhaust particles
enhance influenza virus infection in human airway
epithelial cells and the enhanced susceptibility to diesel
exhaust by influenza infection is associated with
decreased surfactant protein expression [32,36]. How-
ever, the interactive effects between virus and pollutant
particle could largely depend on the type of virus and
the composition of the pollutant particle in question.
Air pollution particles are a complex mixture of organic
(e.g., carbon, polycyclic aromatic hydrocarbons) and
inorganic constituents (e.g., transition metals) [5]. Vana-
dium-containing air pollution particles are released at
the highest levels in oil-burning power plants that
Figure 6 Quantification of mRNAs encoding growth factors (TGF-b1, CTGF, PDGF-C) and collagen (Col1A2). The mRNA levels for each
growth factor or collagen was measured by Taqman quantitative real-time RT-PCR. Data were analyzed by One-way ANOVA followed by Tukey’s
test. Comparisons were V2O5 versus Control or V2O5 versus other treatments as indicated. *P < 0.05, **P < 0.01, ***P < 0.001.
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These vanadium-containing fly ash particles then contri-
bute to urban ambient particulates (UAP). Our data in
mice exposed to pure V2O5 suggest that pre-exposure to
RSV infection would not increase the risk to vanadium-
containing UAP. However, it would be important to
determine whether RSV would exacerbate the effects of
vanadium-containing UAP in the lung or whether other
types of viral infections (e.g., influenza) would increase
lung inflammation or fibrosis caused by vanadium-con-
taining UAP or pure V2O5.
Viral infection has been implicated in the pathogenesis
of idiopathic pulmonary fibrosis (IPF). While little is
known about the mechanisms of IPF, the disease is
likely multi-factorial, and viruses have been implicated
as co-factors (either as initiating or exacerbating agents)
of fibrotic lung disease [37]. Specifically, experimental
data suggests a link between hepatitis C virus, adeno-
virus, human cytomegalovirus and the Epstein-Barr
gammaherpesvirus, in IPF [38]. Therefore, despite the
findings of our study, viral infections should be consid-
ered as potential initiators or exacerbating agents in at
least some cases of IPF and possibly other types of occu-
pational and environmental lung diseases that involve
fibrotic responses.
The mechanism(s) through which V2O5 exerts a
fibrogenic effect in the lungs of mice is likely complex
and further confounded by RSV exposure. While V2O5
Figure 7 Quantification of mRNAs encoding type I interferons (IFN-a,I F N - b) and CXC chemokines (CXCL9 and CXCL10).T h em R N A
levels for each cytokine or chemokine was measured by Taqman quantitative real-time RT-PCR. Data were analyzed by One-way ANOVA
followed by Tukey’s test. Comparisons were V2O5 versus Control or V2O5 versus other treatments as indicated. *P < 0.05, **P < 0.01, ***P < 0.001.
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and increased growth factor levels that mediate fibrosis,
V2O5 also increased type I IFNs (IFN-a and IFN-b)
along with IFN-inducible chemokines CXCL10 and
CXCL9. Furthermore, we observed that RSV blocked
V2O5-induced increases in IFN and CXC chemokine
mRNAs. IFNs could be protective against fibrosis by
causing growth arrest and apoptosis of fibroblasts, and
CXCL10 has been reported to have angiostatic proper-
ties [39]. We have also reported that V2O5 is a potent
activator of type I IFN production by lung fibroblasts
that leads to STAT-1 activation and proposed this
mechanism in the resolution V2O5-induced fibrosis [22].
T h eR S Vs u r f a c ea t t a c h m e n tp r o t e i n( Gp r o t e i n )h a s
been shown to inhibit Toll-like receptor (TLR) 3/4-
mediated IFN-b induction [40] a feature that may facili-
tate virus replication. In the present study, we found
that RSV reduces V2O5-induced mRNA levels of type I
IFNs, CXCL9 and CXCL10. Therefore, while RSV
reduces V2O5-induced fibrosis in AKR mice, this effect
is limited by the action of RSV in also reducing poten-
tially protective IFNs and chemokines.
Finally, it may be noteworthy that certain metals, includ-
ing vanadium, possess broad spectrum anti-viral activity
that includes inhibition of RSV replication [41]. We did
not specifically address the issue of viral replication in the
lungs of mice exposed to V2O5 in the present study. An
important focus of future study will be to determine if
RSV or other viruses (e.g., influenza) are inhibited by
V2O5 or vanadium-containing air pollutant particles.
Conclusions
The intranasal inoculation of mice with RSV clearly did
not exacerbate V2O5-induced pulmonary inflammation
and fibrosis, but rather reduced these pathologic end-
points and reduced V2O5-induced neutrophil and lym-
phocyte infiltration into the lungs. Moreover, RSV
pre-or post-exposure significantly reduced mRNA levels
of pro-fibrogenic growth factors and collagen, and yet
also reduced RNA levels of anti-fibrogenic interferons
and CXC chemokines. Collectively these data suggest
that RSV infection reduces the severity of V2O5-induced
fibrosis by suppressing pro-fibrogenic growth factors and
collagen genes. However, RSV suppression of V2O5-
induced IFNs and IFN-inducible chemokines also sug-
gests that viral infection has a negative effect on the
immune response triggered by V2O5 exposure. Our find-
ings in mice suggest that RSV infection does not increase
the risk of occupational bronchitis caused by vanadium
exposure. Further studies should address whether occu-
pational lung disease caused by the inhalation of metals
other than vanadium are modulated in a positive or nega-
tive way by RSV infection.
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